ChIP-seq and CUT&Tag profiling of the genome binding of YAP/TAZ-TEAD and SMAD3 in the human HCC cell line HCCLM3 [CUT&Tag]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 24 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Hepatocellular carcinomaThis series is part of our curated briefing on it.
- Samples
- 24 samples: 12 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE330469_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1464454 and SRA study SRP699211. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 24 samples.
How we read this: 12 replicated groups read from 24 sample titles; they account for 24 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9727260 IgG, CUT&Tag, rep1 IgG, CUT&Tag,
- GSM9727261 IgG, CUT&Tag, rep2 IgG, CUT&Tag,
- GSM9727262 Control, SMAD3, CUT&Tag, rep1 Control, SMAD3, CUT&Tag,
- GSM9727263 Control, SMAD3, CUT&Tag, rep2 Control, SMAD3, CUT&Tag,
- GSM9727264 Control, TEAD1, CUT&Tag, rep1 Control, TEAD1, CUT&Tag,
- GSM9727265 Control, TEAD1, CUT&Tag, rep2 Control, TEAD1, CUT&Tag,
- GSM9727266 Control, VGLL4, CUT&Tag, rep1 Control, VGLL4, CUT&Tag,
- GSM9727267 Control, VGLL4, CUT&Tag, rep2 Control, VGLL4, CUT&Tag,
- GSM9727268 TGFb1, SMAD3, CUT&Tag, rep1 TGFb1, SMAD3, CUT&Tag,
- GSM9727269 TGFb1, SMAD3, CUT&Tag, rep2 TGFb1, SMAD3, CUT&Tag,
- GSM9727270 TGFb1, TEAD1, CUT&Tag, rep1 TGFb1, TEAD1, CUT&Tag,
- GSM9727271 TGFb1, TEAD1, CUT&Tag, rep2 TGFb1, TEAD1, CUT&Tag,
- GSM9727272 TGFb1, VGLL4, CUT&Tag, rep1 TGFb1, VGLL4, CUT&Tag,
- GSM9727273 TGFb1, VGLL4, CUT&Tag, rep2 TGFb1, VGLL4, CUT&Tag,
- GSM9727274 siYAP/TAZ, TGFb1, SMAD3, CUT&Tag, rep1 siYAP/TAZ, TGFb1, SMAD3…
- GSM9727275 siYAP/TAZ, TGFb1, SMAD3, CUT&Tag, rep2 siYAP/TAZ, TGFb1, SMAD3…
- GSM9727276 siYAP/TAZ, TGFb1, TEAD1, CUT&Tag, rep1 siYAP/TAZ, TGFb1, TEAD1…
- GSM9727277 siYAP/TAZ, TGFb1, TEAD1, CUT&Tag, rep2 siYAP/TAZ, TGFb1, TEAD1…
- GSM9727278 siYAP/TAZ, TGFb1, VGLL4, CUT&Tag, rep1 siYAP/TAZ, TGFb1, VGLL4…
- GSM9727279 siYAP/TAZ, TGFb1, VGLL4, CUT&Tag, rep2 siYAP/TAZ, TGFb1, VGLL4…
- GSM9727280 KLF2, TGFb1, SMAD3, CUT&Tag, rep1 KLF2, TGFb1, SMAD3, CUT…
- GSM9727281 KLF2, TGFb1, SMAD3, CUT&Tag, rep2 KLF2, TGFb1, SMAD3, CUT…
- GSM9727282 KLF2, TGFb1, TEAD1, CUT&Tag, rep1 KLF2, TGFb1, TEAD1, CUT…
- GSM9727283 KLF2, TGFb1, TEAD1, CUT&Tag, rep2 KLF2, TGFb1, TEAD1, CUT…
- GSE14520 Gene expression data of human hepatocellular carcinoma (HCC) 488 samples same disease briefing · shares hcc
- GSE114564 Identification of novel serum biomarkers in early-stage HCC patients. 118 samples same disease briefing · shares hcc
- GSE10143 Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma 387 samples same disease briefing
- GSE107170 Molecular Signature of Hepatitis D Virus-Associated Hepatocellular Carcinoma 307 samples same disease briefing
- GSE109211 Molecular predictors of prevention of recurrence in hepatocellular carcinoma with sorafenib as adjuvant treatment in the phase 3 STORM trial 140 samples same disease briefing
- GSE10186 Integrative Transcriptome Analysis Reveals Common Molecular Subtypes of Human Hepatocellular Carcinoma 118 samples same disease briefing
- GSE105130 Comprehensive analysis of Transcriptome Profiles in Hepatocellular Carcinoma patients 52 samples same disease briefing
- GSE140228 Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma 41 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.